ArticleScientific reports2025
Analysis of DNA methyltransferase 3 alpha expression during respiratory syncytial virus strain A infection.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Respiratory syncytial virus (RSV) is a seasonal pathogen known to cause lower respiratory tract infections, including bronchiolitis and pneumonia, and it is associated with an increased risk of developing asthma and recurrent wheezing in pediatric populations. Epigenetic mechanisms, such as DNA methylation and histone modifications, have been implicated in regulating host immune responses during viral infections. In this study, we investigated DNMT3A expression, a de novo DNA methyltransferase, during RSV infection. We queried the Gene Expression Omnibus (GEO) database for RNA-sequencing datasets related to RSV infection. Among the five relevant datasets identified, one demonstrated significantly elevated DNMT3A expression in RSV-infected samples compared to controls. To validate and further examine this finding, we infected MRC-5 cells, a human lung fibroblast cell line, with RSV-A strain (RSV-A2) and accessed DNMT3A expression at different time points using real-time RT-qPCR. We observed an upregulation of DNMT3A expression at 8 h post-infection; this induction was decreased in the presence of rapamycin, an inhibitor of the mTOR pathway. Immunofluorescence analysis confirms DNMT3A presence in RSV-infected cells. In vivo analysis revealed a significant increase in Dnmt3a expression in murine lung tissue five days following RSV infection. In ex-vivo RSV-infected pediatric lung tissue sample the DNMT3A gene expression was not increase compared to uninfected tissue. Our findings suggest that RSV modulates DNMT3A expression through mTOR pathway, but this effect is transient and dependent on the sample and the kinetics of infection. Our data highlights a potential epigenetic mechanism involved in the gene expression regulation of the host during infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.